Carcinogenesis, Vol 18, 1985-1991, Copyright © 1997 by Oxford University Press
T Sakuma, T Igarashi, M Hieda, S Ohgiya, M Isogai, S Ninomiya, R Nagata, N Nemoto and T Kamataki
Complementary DNA of marmoset CYP1A2 was isolated by means of screening the
cDNA library and reverse-transcriptase polymerase chain reaction. The
deduced amino acid sequence of marmoset CYP1A2 consisted of 516 residues
and showed 88.2 and 90.0% identities to corresponding forms in human and
cynomolgus monkey, respectively. S1 nuclease protection assay demonstrated
that CYP1A2 mRNA was expressed constitutively in the liver, but not in the
lung, kidney and small intestine. The level of CYP1A2 mRNA in the liver was
increased by treatment with 3- methylcholanthrene and polychlorinated
biphenyls. Marmoset CYP1A2 expressed in recombinant yeast activated
2-amino-3-methylimidazo [4,5- f]quinoline (IQ) and
2-amino-3,8-dimethylimidazo [4,5-f]quinoxaline (MeIQx) efficiently, and
also activated 2-amino-1-methyl-6- phenylimidazo [4,5-b]pyridine (PhIP),
but at a relatively lower rate in the umu mutagenicity test. Marmoset
CYP1A2 also showed ethoxyresorufin O-de-ethylase activity. Based on these
results, we demonstrate that marmosets constitutively express CYP1A2 in the
liver as in humans.
ARTICLES
Marmoset CYP1A2: primary structure and constitutive expression in livers
Division of Drug Metabolism, Faculty of Pharmaceutical Sciences, Hokkaido University, Japan.
![]()
CiteULike
Connotea
Del.icio.us What's this?